There are reports of deals between the Trump administration and pharmaceutical companies aimed at lowering prescription drug prices. However, the effectiveness of these deals in achieving price reductions is uncertain, with some outlets indicating that many drug prices have increased despite the agreements. The actual impact of the deals on drug prices and potential savings is a matter of conflicting reports and ongoing scrutiny.